Synthesis, polymorphs, and pharmaceutical formulation of FAAH inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 15, 2011
Grant Date -
Jan 29, 2009
app pub date -
Aug 16, 2007
filing date -
Aug 21, 2006
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Pharmacological inhibition of fatty acid amide hydrolase (FAAH) activity leads to increased levels of fatty acid amides. The alkylcarbamic acid aryl ester of Formula (I), KDS-4103, is a FAAH inhibitor. Described herein is a process for the preparation of the compound of Formula (I), characterization of polymorphs of the FAAH inhibitor, and their uses therof.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully